Dr. Galsky on Sequencing Questions in Urothelial Cancer
1 Views
administrator
07/18/23
Matthew Galsky, MD, a professor of medicine; director of Genitourinary Medical Oncology; director of the Novel Therapeutics Unit; and co-director of the Center of Excellence for Bladder Cancer at the Tisch Cancer Institute and the Icahn School of Medicine at Mount Sinai, discusses sequencing questions in urothelial cancer.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
-
Category
Show more
Facebook Comments
No comments found